Breakthrough Computational Genomics Uncovers Unique Genetic Fingerprint for Rapid and Highly Accurate Ebola Virus Diagnosis

WFIRM researchers pinpoint 281 genes unique to Ebola, creating a genetic fingerprint to identify the virus with 95% accuracy and improve outbreak response.

By: AXL Media

Published: Apr 30, 2026, 10:05 AM EDT

Source: Information for this report was sourced from EurekAlert!

Decoding the Molecular Signature of a Deadly Pathogen

Medical diagnostics has reached a significant milestone as scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) isolated a specific gene pattern that distinguishes Ebola from other viral threats. Historically, the human body’s immune system responds to various infections in remarkably similar ways, creating a "noise" of shared genetic signals that obscures the unique identity of specific viruses. By utilizing advanced computational genomics, researchers have successfully bypassed these common immune markers. This breakthrough, published in Frontiers in Genetics, provides a roadmap for detecting one of the world's most dangerous pathogens by focusing on how the host specifically reacts to it.

Advanced Filtering of Shared Biological Signals

The core of the discovery lies in the systematic removal of shared biological data that often leads to diagnostic confusion. Lead author Mostafa Rezapour explained that many infections trigger nearly identical gene expressions, which makes traditional analysis difficult. To overcome this, the WFIRM team compared blood samples from Ebola-infected subjects against a wide array of other illnesses, including COVID-19, influenza, mpox, HIV, and bacterial pneumonia. By subtracting the genes that were active across all these conditions, the researchers were able to pinpoint 281 genes that are activated exclusively during an Ebola infection, providing a level of specificity previously thought unattainable.

Developing the Ninety Five Percent Accuracy Fingerprint

From the broader pool of Ebola-specific genes, the research team distilled a refined set of 50 high-priority genes to create a definitive "genetic fingerprint." In testing, this molecular profile correctly identified Ebola cases with 95% accuracy. This high degree of precision is vital for clinical settings, particularly in the early stages of an outbreak where distinguishing between a common flu and a highly contagious hemorrhagic fever can prevent mass casualties. Anthony Atala, director of WFIRM, noted that this host-response strategy allows for the identification of dangerous pathogens even when traditional diagnostic methods might struggle to find a clear signal.